ArticleAsian Pacific journal of cancer prevention : APJCP2019

Anlotinib Combined with S-1 in the Third-Line Treatment of Stage IV Non-Small Cell Lung Cancer: Study Protocol for Phase II Clinical Trial.

Xiyue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.